Table 1 Summary of studies included
Author | Year | Study Type | Number of patients | Number of patients with Diabetes | Number of diabetic patients with neuropathy | Sex | Age (Range) of DM patients | BMI |
|---|---|---|---|---|---|---|---|---|
Andersen | 2004 | cross-sectional | 46 | 23 (Type 1 Diabetes) | 15 | 16 M:7F | 46 (27–62) | 73 kg (53–92) |
Andreassen | 2009 | case control | 26 | 12 | 4 | 12 M:8F | 56 (45–76) | 73 kg (54–100) |
Bus | 2002 | case control | 18 | 8 | 8 | 6 M:2F | 51.6 ± 11.1 | 87.8 ± 16.2 |
Bus | 2009 | cross-sectional | 20 | 20 | 10 (+ Claw Deformity) | 12 M:8F | 58.5 ± 7.1 (claw toe group) | 27.3 ± 3.2 (Claw toe group) |
Cheuy | 2013 | case control | 19 | 12 | NOS | 9 M:10F | 57 ± 12 in the diabetic polyneuropathy group | 114 kg (21) |
Greenman | 2005 | case control | 33 | 21 | 12 | 14 M:5F | 56.7 ± 8.38 (non-neuropathic); 51 ± 7(neuropathic) | 32 ± 6 (non-neuropathic group)33 ± 4.7 (neuropathic group) |
Lue | 2022 | case control | 102 | 63 | NOS | 60 M:42F | 55.3 ± 10.5 | 33.1 ± 9.5 |